Control subjects showed higher plasma levels of Netrin-1 as compared to CAD patients (Figure 1A) and a negative trend (r = −0.306, p = 0.014) is observed from controls to SA and AMI patients. This evidence concerns the gene NTN1 and coronary artery disorder.